⌘K

Login Start Free

Home/Filings/4/0001363585-14-000003

4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001363585-14-000003

CIK 0001059784operating

View on SEC.gov Company Profile

Filed

Oct 7, 8:00 PM ET

Accepted

Oct 8, 3:38 PM ET

Size

6.6 KB

Accession

0001363585-14-000003

Insider Transaction Report

Form 4

Period: 2014-10-06

GENEREX BIOTECHNOLOGY CORPGNBT

EVP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2014-10-06$0.00/sh+470,726$471→ 470,726 total
Exercise/Conversion
Common Stock Purchase Option (Right to Buy)
2014-10-06−470,726→ 0 total
Exercise: $0.00From: 2005-04-05Exp: 2014-10-26→ Common Stock (470,726 underlying)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001059784

Filing Metadata

Form type: 4
Filed: Oct 7, 8:00 PM ET
Accepted: Oct 8, 3:38 PM ET
Size: 6.6 KB

View on SEC.gov